Compounds having activity as inhibitors of the JNK pathway are disclosed.
The compounds of this invention are anilinopyrimidine derivatives having
the following structure: ##STR00001## wherein R.sub.1 through R.sub.6
are as defined herein. Such compounds have utility in the treatment of a
wide range of conditions that are responsive to inhibition of the JNK
pathway. Thus, methods of treating such conditions are also disclosed, as
are pharmaceutical compositions containing one or more compounds of the
above compounds.